Market News & Trends
Oncology Leads Development in Promising Gene Therapy Pipeline
Despite few products having so far reached the market and captured strong revenues, the gene therapy pipeline remains large, with 906 products in active development…
Drug Development & Delivery to Launch Innovation Networking Event
Drug Development & Delivery President & Publisher Ralph Vitaro recently announced that the leading media company will be hosting the inaugural Innovation Networking Summit &…
Dimension Therapeutics Announces FDA Fast Track Designation
Dimension Therapeutics, Inc. recently announced that the US FDA has granted Fast Track designation for the company’s lead product candidate, DTX101, for the treatment of…
West Pharmaceutical Services & Healthprize Technologies Announce Self-Reporting & Barcoding Capabilities for Self-Injection Technology
West Pharmaceutical Services, Inc. and HealthPrize Technologies, LLC, recently announced the completion of the first two phases of their four-phase strategic collaboration. The companies are…
Theravance Biopharma & Mylan Initiate Phase III Program
Theravance Biopharma, Inc. and Mylan N.V. recently announced the initiation of a Phase III program for revefenacin (TD-4208), an investigational long-acting muscarinic antagonist (LAMA) in…
Lpath Initiates First-in-Human Dosing in Phase I Trial
Lpath, Inc. recently announced that the first cohort of six subjects has been dosed in the Phase I clinical trial with Lpathomab. The double-blind, placebo-controlled,…
EMD Millipore Introduces Enhancements to its EMPROVE® Program
EMD Millipore Introduces Enhancements to its EMPROVE® Program EMD Millipore recently introduced enhancements to its industry-leading EMPROVE portfolio of pharmaceutical raw materials. The expanded documentation…
Benign Prostatic Hyperplasia Treatment Market Value to Reach Nearly $5 Billion
The value of the global therapeutics market for Benign Prostatic Hyperplasia (BPH) will rise from just over $2 billion in 2014 to approximately $4.9 billion…
Science-Based Technology Selection & Formulation Development for Oral Bioavailability Enhancement
Capsugel Dosage Form Solutions White Paper Authors: Hywel Williams, Michael Morgen, Eduardo Jule, Jan Vertommen, Hassan Benameur, Dwayne Friesen and David Vodak Introduction The increasing…
Enable Injections Completes its First-In-Human Wearable Injector Pilot Trial
Enable Injections recently announced it has completed its first-in-human pilot trial. The study evaluated dose delivery, injection pain, and ease of use in subcutaneous self-delivery.…
Aragen Bioscience Announces Licensing Agreement for Protein Production Technology
Aragen Bioscience, Inc. recently announced it has entered into an agreement with ProteoNic Biotechnology BV for the commercial use of ProteoNic’s 2G UNic recombinant protein…
FDA Accepts First Digital Medicine New Drug Application
Otsuka Pharmaceutical Co., Ltd. and Proteus Digital Health recently announced the US FDA has determined that the New Drug Application for the combination product of…
US Patent Granted for Use of Genticel’s Antigen Delivery Vectors
Genticel recently announced that a new patent (No. 9,095,537), Therapy of Cancer Based on Targeting Adaptive, Innate and/or Regulatory Component of the Immune Response,…
Oramed Completes Randomization of Over 50% of Patients in Phase IIb Study
Oramed Pharmaceuticals Inc. recently announced that 98 patients have already been enrolled in the company’s Phase IIb study of its oral insulin capsule, ORMD-0801, which…
Lubrizol CDMO Acquisition Significantly Broadens its Capabilities
The Lubrizol Corporation recently announced it has acquired Particle Sciences, a leading contract drug development and manufacturing organization with a comprehensive suite of services for…
Downstream Processing - BioProcess International Conference Pre-Event Podcast Series
Hear talk previews from Recovery & Purification + Analytcal, Quality, and Formulations speakers Characterization of Host-Cell Proteins Using Mass Spectrometry Enables Effective Purification Optimization…
Global Non-Small Cell Lung Cancer Treatment Market Value to Approach $11 Billion
The global market value for Non-Small Cell Lung Cancer (NSCLC) treatment will increase from $6.9 billion in 2014 to $10.9 billion by 2021, representing a…
Glenmark Pharmaceuticals' Novel Monoclonal Antibody to Enter Phase II
Glenmark Pharmaceuticals S.A. recently announced that GBR 830, a novel monoclonal antibody has completed clinical Phase I dosing. GBR 830 is an antagonist of OX40,…
Chugai Pharmaceutical’s Bispecific Antibody Designated as Breakthrough Therapy
Chugai Pharmaceutical Co., Ltd. recently announced today the US FDA has granted the Breakthrough Therapy Designation to ACE910 for the prophylactic treatment of people who…
Alvogen Launches First Generic Exelon Patch in the US
Alvogen recently announced it has launched the first generic equivalent of Exelon patch (rivastigmine transdermal system) in the US. The product will be marketed by…